- Home
- SOAR vs CHEK Comparison
SOAR vs CHEK Comparison
Compare SOAR & CHEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOAR
- CHEK
- Stock Information
- Founded
- SOAR 2021
- CHEK 2004
- Country
- SOAR United States
- CHEK Israel
- Employees
- SOAR N/A
- CHEK N/A
- Industry
- SOAR Blank Checks
- CHEK Medical Electronics
- Sector
- SOAR Finance
- CHEK Health Care
- Exchange
- SOAR Nasdaq
- CHEK Nasdaq
- Market Cap
- SOAR 3.8M
- CHEK 4.5M
- IPO Year
- SOAR N/A
- CHEK 2015
- Fundamental
- Price
- SOAR $1.63
- CHEK $0.81
- Analyst Decision
- SOAR
- CHEK
- Analyst Count
- SOAR 0
- CHEK 0
- Target Price
- SOAR N/A
- CHEK N/A
- AVG Volume (30 Days)
- SOAR 404.0K
- CHEK 52.9K
- Earning Date
- SOAR 05-14-2025
- CHEK 05-14-2025
- Dividend Yield
- SOAR N/A
- CHEK N/A
- EPS Growth
- SOAR N/A
- CHEK N/A
- EPS
- SOAR N/A
- CHEK N/A
- Revenue
- SOAR $46,288,000.00
- CHEK N/A
- Revenue This Year
- SOAR N/A
- CHEK N/A
- Revenue Next Year
- SOAR N/A
- CHEK N/A
- P/E Ratio
- SOAR N/A
- CHEK N/A
- Revenue Growth
- SOAR 97.25
- CHEK N/A
- 52 Week Low
- SOAR $1.31
- CHEK $0.56
- 52 Week High
- SOAR $90.00
- CHEK $3.04
- Technical
- Relative Strength Index (RSI)
- SOAR 34.61
- CHEK 47.11
- Support Level
- SOAR $1.31
- CHEK $0.77
- Resistance Level
- SOAR $2.24
- CHEK $0.86
- Average True Range (ATR)
- SOAR 0.25
- CHEK 0.08
- MACD
- SOAR 0.08
- CHEK 0.00
- Stochastic Oscillator
- SOAR 31.07
- CHEK 41.46
About SOAR Volato Group Inc.
Volato Group Inc operates an aircraft ownership program, provides ad-hoc charter flights, sells deposit products, and manages aircraft for owners in the private aviation industry. It offers fractional ownership, aircraft management, jet cards, deposit, and charter programs. The company's fractional programs provides flexible hours and a revenue share for owners in a fleet of HondaJets, optimized for missions of up to four passengers.
About CHEK Check-Cap Ltd.
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.